By David Parsley2022-11-14T11:17:00
UBS Asset Management and Reef Group have completed the purchase of development land that sits alongside GSK’s 1m sq ft research and development scheme in Stevenage.
UBS Asset Management and Reef Group, which bought the site from the pharmaceutical giant, are set to invest up to £900m to develop the 33 acres of land adjacent to GSK’s R&D hub to create a combined campus of 2.5m sq ft of laboratory and office facilities.
You must be logged in to continue
Register for free to finish this article.
Sign up now for the following benefits:
To access this article REGISTER NOW
Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £6 per week.